PubMed (GeneRIF) for id: 10516

Year	Number of Results
2002	1
2003	1
2004	2
2005	1
2006	4
2007	4
2008	5
2009	13
2010	10
2011	6
2012	5
2013	3
2014	5
2015	11
2016	7
2017	2
2018	3
2019	7
2020	6
2021	3
2022	2
2023	2
2024	1

1

Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC.

Masood M, Ding Q, Cawte AD, Rueda DS, Grimm SW, Yagüe E, El-Bahrawy M. Masood M, et al. Cell Commun Signal. 2023 Oct 20;21(1):295. doi: 10.1186/s12964-023-01300-3. Cell Commun Signal. 2023. PMID: 37864183 Free PMC article.

2

FBLN5 was Regulated by PRDM9, and Promoted Senescence and Osteogenic Differentiation of Human Periodontal Ligament Stem Cells.

Zhao M, Rong R, Zhang C, Yang H, Han X, Fan Z, Zheng Y, Zhang J. Zhao M, et al. Curr Stem Cell Res Ther. 2024;19(3):417-425. doi: 10.2174/1574888X18666230822100054. Curr Stem Cell Res Ther. 2024. PMID: 37608663 Free PMC article.

3

Genetic variants and haplotypes in fibulin-5 (FBLN5) are associated with pseudoexfoliation glaucoma but not with pseudoexfoliation syndrome.

Kapuganti RS, Bharati B, Mohanty PP, Alone DP. Kapuganti RS, et al. Biosci Rep. 2023 Mar 31;43(3):BSR20221622. doi: 10.1042/BSR20221622. Biosci Rep. 2023. PMID: 36794549 Free PMC article.

4

Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).

Li Y, Yang X, Lu D. Li Y, et al. Bioengineered. 2022 May;13(5):11867-11880. doi: 10.1080/21655979.2022.2060162. Bioengineered. 2022. PMID: 35543375 Free PMC article.

5

Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.

García-Valero J, Olloquequi J, Rodríguez E, Martín-Satué M, Texidó L, Ferrer J. García-Valero J, et al. Arch Bronconeumol. 2022 Jun;58(6):482-489. doi: 10.1016/j.arbres.2020.12.032. Epub 2021 Jan 27. Arch Bronconeumol. 2022. PMID: 35312591 English, Spanish.

6

MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.

Huang M, Liao X, Li L, Li G, Chen M. Huang M, et al. Tissue Cell. 2021 Dec;73:101672. doi: 10.1016/j.tice.2021.101672. Epub 2021 Oct 29. Tissue Cell. 2021. PMID: 34736163

7

PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.

Sun B, Tomita B, Salinger A, Tilvawala RR, Li L, Hakami H, Liu T, Tsoyi K, Rosas IO, Reinhardt DP, Thompson PR, Ho IC. Sun B, et al. Matrix Biol. 2021 Aug;102:70-84. doi: 10.1016/j.matbio.2021.07.001. Epub 2021 Jul 15. Matrix Biol. 2021. PMID: 34274450 Free PMC article.

8

FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma.

Li R, Wu H, Jiang H, Wang Q, Dou Z, Ma H, Yan S, Yuan C, Yang N, Kong B. Li R, et al. Oncol Rep. 2020 Nov;44(5):2143-2151. doi: 10.3892/or.2020.7749. Epub 2020 Sep 3. Oncol Rep. 2020. PMID: 32901854 Free PMC article.

9

Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.

Safka Brozkova D, Stojkovic T, Haberlová J, Mazanec R, Windhager R, Fernandes Rosenegger P, Hacker S, Züchner S, Kochański A, Leonard-Louis S, Francou B, Latour P, Senderek J, Seeman P, Auer-Grumbach M. Safka Brozkova D, et al. Eur J Neurol. 2020 Dec;27(12):2568-2574. doi: 10.1111/ene.14463. Epub 2020 Sep 5. Eur J Neurol. 2020. PMID: 32757322

10

Evaluation of the fibulin 5 gene polymorphism as a factor related to the occurrence of pelvic organ prolapse.

Paula MVB, Lira Júnior MAF, Monteiro VCESC, Souto RP, Fernandes CE, Oliveira E. Paula MVB, et al. Rev Assoc Med Bras (1992). 2020 May;66(5):680-686. doi: 10.1590/1806-9282.66.5.680. Epub 2020 Jul 3. Rev Assoc Med Bras (1992). 2020. PMID: 32638975 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year